eXoZymes, Inc. (EXOZ)

eXoZymes, Inc. (EXOZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $38.3M; returns 1 day +2.6%, 1 week -2.2%, 1 year -66.7%.

eXoZymes, Inc. is a development-stage synthetic biology company that engineers enzymes using artificial intelligence for cell-free biomanufacturing. The company's proprietary platform creates 'exozymes,' which are AI-enhanced enzymes designed to operate outside of a living cell, transforming sustainable feedstocks like sugar and biomass into high-value small molecules.

Groups EXOZ belongs to

• Artificial Intelligence
• Clinical Stage
• Preclinical Development
• Biotechnology
• R&D
• Sustainable Materials
• Clean Technology
• AI in Healthcare

EXOZ financial model: income statement, cash flow and balance sheet